Tuesday, 4 August 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 4 August 2026
IQVIA
IQVIA
$300M blockbuster falls off patent cliff

A blockbuster is taking a $75 million hit to annual earnings after diving off a patent cliff along with four other medicines which have also lost exclusivity.

Who's jumped ship to be first CMO?
A pharma filling its first Chief Medical Officer position has landed an industry veteran with extensive experience in launching new indications
Med affairs, the time is now
A call to action has sounded: This cross-disciplinary team is urging a fundamental change to how Medical Affairs reach HCPs
TODAY
Eight pharmas win PBS listings
A wave of PBS listings for August with more than half covering new medicines including the first new treatment option in 20 years
3 August
AZ, BMS in monster merger talks
A record-breaking pharmaceutical merger may be in the making, with AstraZeneca and BMS reportedly in talks
3 August
Will this drug finally reach Aust?
Four years on, this company is having another tilt at bringing its long-acting drug to Australia and it's actively pursing public funding
3 August
Goodbyes: Look who's leaving now
As industry continues to undergo change, so does the Aussie workforce with a number of high-profile exits
31 July
HPG
HPG
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (18)

Access & Reimbursement (2)

Clinical & Medical, R&D (11)

Regulatory, Pharmacovigilance & QA (3)

Devices (1)

Executive Roles (2)

Other (12)

Brown nosing allowed, court rules
The Full Federal Court has come down in favour of the National Cancer Foundation's 'somewhat confronting' Brown Nose campaign
3 August
GSK, generic makers win TGA nod
New drug considered by the PBAC at its July meeting approved along with two generics of PBS listed medicines
3 August Approvals Action
Pharma the latest Prick on the road
A local pharma was behind a stunt that saw many Sydneysiders bemused when they encountered a particular car driving from the city to the surf
31 July
Pharma most-mentioned by AI
Who's named most often in AI generated answers about pharma and when it comes to brand reputation does high-visibility count?
31 July
Where will this exec land next?
ICYMI: Where is he going? J&J leader hush-hush on next move plus the other most popular stories this week
31 July
Drug short opens new care play
Supply problems seen as an opportunity to educate patients about new care guidelines introduced last year
31 July
Aussie boss roasted on LinkedIn
Debate about whether his latest decision was nothing more than a 'giant pain in the ass' for staff or an attempt 'To Do an AZ'
30 July
Inside PBAC's special meeting
The committee will meet today to discuss a matter that cannot reasonably be deferred to the next scheduled meeting
30 July
Pharmas earning the most bucks
Fortune Magazine has published its list of the top 500 earning companies, and a baker's dozen of pharmas made the grade
30 July
Lilly, Roche sign Alzheimer's plan
Rather than wait for HTA processes, the two pharmas have teamed with NeuRA to pilot a new model of care in detecting and treating Alzheimer's
30 July
CSL's next-gen tech ready for trials
The Aussie giant is looking for evidence to support the regulatory approval of a more efficient manufacturing process
30 July
Rebel weighs in on GLP1s
Aussie movie star who shed 36kgs backs new wellness campaign that advocates the new trend of 'microdosing' of weight loss meds
29 July
Pharma unveils $3.6B restructure
Global CEO declined to provide details on the number of jobs to go following an enterprise-wide review of the company's cost base
29 July
13 times a Great Place to Work
This pharma has once again been certified as a Great Place to Work, marking 13 consecutive years of certification
29 July
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.